Spots Global Cancer Trial Database for stage iii lung cancer

Every month we try and update this database with for stage iii lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources	NCT06383988	Stage II Lung C... Stage III Lung ... Stage IV Lung C...	Support for Car... Support for Car... Internet-Based ... Patient Navigat...	18 Years -	Wake Forest University Health Sciences
External ValidatIon Trial of ASTER Trial	NCT01332240	Stage III Lung ...	Endoscopic ultr...	18 Years - 95 Years	Universitaire Ziekenhuizen KU Leuven
Lung Cancer Informational Study (LCIS)	NCT00579215	Cancer Enhanced Care Decision-Making Advance Lung Ca... Stage III Lung ... Stage IV Lung C...	Enhance Care Usual Care	-	Memorial Sloan Kettering Cancer Center
External ValidatIon Trial of ASTER Trial	NCT01332240	Stage III Lung ...	Endoscopic ultr...	18 Years - 95 Years	Universitaire Ziekenhuizen KU Leuven
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC	NCT05641870	Lung Cancer Stage III Lung ... Unresectable Lu...	Sample collecti... Characterizatio... Chemoradiation ... Genomic and met...	18 Years -	Parc de Salut Mar
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC	NCT05641870	Lung Cancer Stage III Lung ... Unresectable Lu...	Sample collecti... Characterizatio... Chemoradiation ... Genomic and met...	18 Years -	Parc de Salut Mar
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer	NCT06140407	Limited Stage L... Stage I Lung Ca... Stage II Lung C... Stage III Lung ...	Cisplatin Carboplatin Etoposide Pembrolizumab Computed Tomogr... Positron Emissi... Magnetic Resona... Biospecimen Col... Radiation Thera...	18 Years -	Vanderbilt-Ingram Cancer Center
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners	NCT03112668	Malignant Femal... Malignant Hepat... Partner Stage III Breas... Stage III Cervi... Stage III Color... Stage III Lung ... Stage III Prost... Stage III Skin ... Stage III Uteri... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Skin... Stage IIIA Uter... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Skin... Stage IIIB Uter... Stage IIIC Brea... Stage IIIC Colo... Stage IIIC Skin... Stage IIIC Uter... Stage IV Breast... Stage IV Cervic... Stage IV Colore... Stage IV Lung C... Stage IV Prosta... Stage IV Skin M... Stage IV Uterin... Stage IVA Cervi... Stage IVA Color... Stage IVA Uteri... Stage IVB Cervi... Stage IVB Color... Stage IVB Uteri...	Cognitive Behav... Quality-of-Life... Questionnaire A... Survey Administ...	18 Years -	Rutgers, The State University of New Jersey
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs	NCT04985357	Stage III Breas... Stage IV Breast... Stage III Lung ... Stage IV Lung C... AML Multiple Myelom... Carcinoma Carcinoma, Panc... Carcinoma of Lu... Carcinoma, Non-... Carcinoma Breas... Carcinoma Prost... Carcinoma, Hepa... Carcinoma, Rena... Carcinoma, Neur... Carcinoma, Smal... Carcinoma, Ovar... Carcinoma Bladd... Carcinoma of Es... Carcinoma Cervi... Carcinoma, Thym... Carcinoma, Duct... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of Un... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Malignant Pleur... Malignant Ascit... Mesothelioma Cholangiocarcin...		18 Years -	Travera Inc
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC	NCT05641870	Lung Cancer Stage III Lung ... Unresectable Lu...	Sample collecti... Characterizatio... Chemoradiation ... Genomic and met...	18 Years -	Parc de Salut Mar
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer	NCT05501665	Lung Non-Small ... Stage IV Lung C... Stage III Lung ...	Biospecimen Col... Carboplatin Computed Tomogr... Fludeoxyglucose... Nab-paclitaxel Pembrolizumab Pemetrexed Positron Emissi... Radiation Thera... [18-F] (fluorop... Ipilimumab Nivolumab Cemiplimab Atezolizumab	18 Years -	Vanderbilt-Ingram Cancer Center
Ask Questions (ASQ):Implementation of a Communication Intervention	NCT05025748	Stage II Breast... Stage III Breas... Stage IV Breast... Stage II Colore... Stage III Color... Stage IV Colore... Stage II Lung C... Stage III Lung ... Stage IV Lung C... Stage II Prosta... Stage III Prost... Stage IV Prosta... Stage II Ovaria... Stage III Ovari... Stage IV Ovaria... Stage II Cervic... Stage III Cervi... Stage II Bladde... Stage III Bladd... Stage IV Bladde... Stage II Kidney... Stage III Kidne... Stage IV Kidney...	Behavioral Inte...	18 Years -	Barbara Ann Karmanos Cancer Institute
External ValidatIon Trial of ASTER Trial	NCT01332240	Stage III Lung ...	Endoscopic ultr...	18 Years - 95 Years	Universitaire Ziekenhuizen KU Leuven

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: